Literature DB >> 33001357

LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA6.

Haiqing He1, Shuiqing Wu1, Kai Ai1, Ran Xu1, Zhaohui Zhong1, Yinhuai Wang1, Lei Zhang1, Xiaokun Zhao2, Xuan Zhu3.   

Abstract

PURPOSE: Ca2+ homeostasis plays a pivotal role in regulating proliferation and apoptosis during cancer development. This study intended to examine the potential tumor-suppressing role of ZNF503 antisense RNA 1 (ZNF503-AS1) in bladder cancer, which may be implicated in the regulation of Ca2+ homeostasis.
METHODS: Differentially expressed long non-coding RNAs (lncRNAs) related to bladder cancer were identified using microarray analysis, followed by the verification of transcription factors to which they bind. The relationship between ZNF503-AS1, GATA6 and SLC8A1 was assessed using dual luciferase reporter, RIP and ChIP assays. The expression levels of ZNF503-AS1, GATA6 and SLC8A1 were modulated to examine their effects on the tumorigenic potential, intracellular Ca2+ concentration and Ca2+-ATPase activity in bladder cancer cells. The in vivo tumorigenic ability was validated in nude mice.
RESULTS: Microarray-based expression profile analysis of the GEO GSE61615 dataset revealed that the expression of ZNF503-AS1 was decreased in bladder cancer. Subsequently, we found that ZNF503-AS1 can bind to the transcription factor GATA6 to up-regulate the expression of SLC8A1. ZNF503-AS1 and SLC8A1 were found to be down-regulated in both primary bladder cancer tissues and cells. Exogenous overexpression of ZNF503-AS1 or SLC8A1 attenuated bladder cancer cell proliferation, invasion and migration, but promoted their apoptosis, accompanied by decreased Ca2+-ATPase activities and increased intracellular Ca2+ concentrations. Additional in vivo experiments validated the inhibitory effect of ZNF503-AS1 overexpression on the tumorigenic capacity of bladder cancer cells in nude mice.
CONCLUSION: ZNF503-AS1 can recruit transcription factor GATA6 to up-regulate SLC8A1 expression, thereby increasing the intracellular Ca2+ concentration and repressing the proliferation, invasion and migration, and enhancing the apoptosis of bladder cancer cells.

Entities:  

Keywords:  Bladder cancer; Ca2+ concentration; GATA6; Invasion and migration; LncRNA; Proliferation; SLC8A1; Transcription factor; ZNF503-AS1

Year:  2020        PMID: 33001357     DOI: 10.1007/s13402-020-00563-z

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  33 in total

Review 1.  Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival.

Authors:  H Llewelyn Roderick; Simon J Cook
Journal:  Nat Rev Cancer       Date:  2008-05       Impact factor: 60.716

2.  Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population.

Authors:  Qiuhan Hua; Xu Lv; Xiang Gu; Yaoyao Chen; Haiyan Chu; Mulong Du; Weida Gong; Meilin Wang; Zhengdong Zhang
Journal:  Mutagenesis       Date:  2016-04-18       Impact factor: 3.000

3.  Bladder cancer.

Authors:  Michelle Grayson
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

4.  Bee venom induces apoptosis through intracellular Ca2+ -modulated intrinsic death pathway in human bladder cancer cells.

Authors:  Siu-Wan Ip; Yung-Lin Chu; Chun-Shu Yu; Po-Yuan Chen; Heng-Chien Ho; Jai-Sing Yang; Hui-Ying Huang; Fu-Shin Chueh; Tung-Yuan Lai; Jing-Gung Chung
Journal:  Int J Urol       Date:  2011-12-11       Impact factor: 3.369

5.  LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.

Authors:  Dong Liu; Yawei Li; Gang Luo; Xingyuan Xiao; Dan Tao; Xinchao Wu; Miao Wang; Chao Huang; Liang Wang; Fuqing Zeng; Guosong Jiang
Journal:  Cancer Lett       Date:  2016-12-18       Impact factor: 8.679

Review 6.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

Authors:  Sebastien Antoni; Jacques Ferlay; Isabelle Soerjomataram; Ariana Znaor; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2016-06-28       Impact factor: 20.096

Review 7.  Bladder cancer.

Authors:  Donald S Kaufman; William U Shipley; Adam S Feldman
Journal:  Lancet       Date:  2009-06-10       Impact factor: 79.321

8.  TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.

Authors:  Junlong Zhuang; Lan Shen; Lin Yang; Xiaojing Huang; Qun Lu; Yangyan Cui; Xi Zheng; Xiaozhi Zhao; Dianzheng Zhang; Ruimin Huang; Hongqian Guo; Jun Yan
Journal:  Theranostics       Date:  2017-07-22       Impact factor: 11.556

9.  Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response.

Authors:  Xabier Agirre; Cem Meydan; Yanwen Jiang; Leire Garate; Ashley S Doane; Zhuoning Li; Akanksha Verma; Bruno Paiva; José I Martín-Subero; Olivier Elemento; Christopher E Mason; Felipe Prosper; Ari Melnick
Journal:  Nat Commun       Date:  2019-02-18       Impact factor: 14.919

Review 10.  Epidemiology, aetiology and screening of bladder cancer.

Authors:  Marcus G K Cumberbatch; Aidan P Noon
Journal:  Transl Androl Urol       Date:  2019-02
View more
  3 in total

1.  Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids.

Authors:  Qingguo Li; Huizhen Sun; Dakui Luo; Lu Gan; Shaobo Mo; Weixing Dai; Lei Liang; Yufei Yang; Midie Xu; Jing Li; Peiyong Zheng; Xinxiang Li; Yan Li; Ziliang Wang
Journal:  J Exp Clin Cancer Res       Date:  2021-11-05

2.  Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis.

Authors:  Song-Tao Xue; Bin Zheng; Shi-Qiang Cao; Jian-Cheng Ding; Guo-Sheng Hu; Wen Liu; Chun Chen
Journal:  Mol Cancer       Date:  2022-03-07       Impact factor: 27.401

3.  lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability.

Authors:  Junfeng Sun; Hangyuan Zhou; Xingqi Bao; Yue Wu; Haowei Jia; Hongchao Zhao; Guanghui Liu
Journal:  Stem Cells Int       Date:  2021-11-23       Impact factor: 5.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.